Loading...
XKRX089980
Market cap206mUSD
Dec 24, Last price  
19,180.00KRW
1D
-0.62%
1Q
-16.97%
Jan 2017
112.40%
IPO
182.89%
Name

Sang-A Frontec Co Ltd

Chart & Performance

D1W1MN
XKRX:089980 chart
P/E
24.93
P/S
1.63
EPS
769.32
Div Yield, %
1.04%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
0.17%
Revenues
183.60b
+1.35%
156,294,804,690153,236,134,031182,073,847,649186,171,234,240153,347,406,708178,480,531,677181,155,503,171183,599,147,400
Net income
11.99b
+61.52%
5,466,770,0417,467,456,81712,063,782,58612,453,879,3532,319,886,7809,298,652,7307,425,752,40011,994,182,126
CFO
28.67b
+105.48%
1,134,498,56123,458,601,3705,998,209,7462,065,410,35510,815,382,00519,609,723,40913,955,118,17128,674,771,110
Dividend
Dec 27, 2023200 KRW/sh

Profile

Sang-A Frontec Co.,Ltd. engages in the research and development, production, and sale of materials/parts based on engineering plastics in South Korea and internationally. The company offers fuel cells; membranes, including vent filters and ePTFE for textiles, as well as membranes for medical use; semiconductor products, such as jar boxes, solar cassettes, FOUP products, wafer carriers, storage boxes, PFA/FEP tubes, and mold release films; medium and large, cylindrical, and small type batteries; and display products comprising cell cassettes, ACF bonding sheets, support bars, and FPD cassettes. It also provides automotive products consisting of air vents, and PTFE tubes and rings; OA products that include wireless charging kits, laser printer/MFP/copy machines, metal sleeves, fuser films, fuser and transfer belts, and guide claws; SG and LX sheet, and backup board PCBs; and medical devices, such as safety filter syringes, epidural needle kits, Green Medi green VACs, and filter needle syringes. The company was founded in 1974 and is headquartered in Incheon, South Korea.
IPO date
Jul 21, 2011
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
183,599,147
1.35%
181,155,503
1.50%
178,480,532
16.39%
Cost of revenue
161,104,657
155,850,168
155,194,901
Unusual Expense (Income)
NOPBT
22,494,490
25,305,336
23,285,631
NOPBT Margin
12.25%
13.97%
13.05%
Operating Taxes
5,009,406
1,425,920
1,507,015
Tax Rate
22.27%
5.63%
6.47%
NOPAT
17,485,084
23,879,416
21,778,616
Net income
11,994,182
61.52%
7,425,752
-20.14%
9,298,653
300.82%
Dividends
(3,118,109)
(3,118,109)
(2,431,181)
Dividend yield
0.90%
0.74%
0.30%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
62,942,650
104,363,906
62,199,079
Long-term debt
39,455,198
9,594,100
35,811,078
Deferred revenue
703,753
761,086
Other long-term liabilities
19,286,194
3,117,356
2,490,583
Net debt
39,584,030
53,457,476
35,152,546
Cash flow
Cash from operating activities
28,674,771
13,955,118
19,609,723
CAPEX
(28,787,838)
(28,418,578)
(40,009,626)
Cash from investing activities
(30,631,861)
(22,007,012)
(31,718,883)
Cash from financing activities
2,239,508
10,300,122
12,315,912
FCF
6,771,452
(582,841)
(14,565,135)
Balance
Cash
56,877,275
51,830,072
56,599,630
Long term investments
5,936,543
8,670,457
6,257,981
Excess cash
53,633,861
51,442,754
53,933,584
Stockholders' equity
125,756,968
123,755,285
120,369,512
Invested Capital
260,115,084
248,767,995
219,386,600
ROIC
6.87%
10.20%
10.85%
ROCE
7.05%
8.26%
8.52%
EV
Common stock shares outstanding
15,591
15,591
15,299
Price
22,300.00
-17.71%
27,100.00
-48.18%
52,300.00
14.44%
Market cap
347,669,109
-17.71%
422,503,715
-47.20%
800,123,056
14.34%
EV
387,253,139
475,961,191
835,275,602
EBITDA
36,075,364
38,030,062
33,910,720
EV/EBITDA
10.73
12.52
24.63
Interest
7,426,763
5,811,229
5,572,386
Interest/NOPBT
33.02%
22.96%
23.93%